Large doses of Ozempic could lead to more severe outcomes, such as kidney failure or cardiovascular diseases
Average Weight Loss Comparison After 72 Weeks Tirzepatide (15 mg) 22.5% Tirzepatide (10 mg) 21.4% Tirzepatide (5 mg) 16.0% Placebo 2.4% These findings highlight Tirzepatides powerful impact on weight loss, making it a highly effective option for those struggling with obesity or weight-related health concerns
It works in the same way as Ozempic in your body
Compare your Week 4 symptom frequency and severity to Week 1
Consulting with a healthcare provider to identify any allergies is critical before starting B12 therapy
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks